Research-Backed Peptide Intelligence

The Science of Peptides, Decoded

Understand peptide research through source-linked compound guides, evidence records and analytical references.

Open Calculator

Follow the evidence

Find the source, check the exact compound and understand the limits.

The Science Behind the Sequence

01

What Are Peptides?

Peptides are short chains of amino acids that act as signaling molecules in the body. Unlike proteins, peptides are small enough to penetrate tissues rapidly and bind to specific receptors with high affinity.

02

Why They Matter

Peptides regulate nearly every biological process — from metabolism and immune response to tissue repair and hormone secretion. Targeted peptide research has opened new frontiers in therapeutic science.

03

Our Approach

Explore research with the study model, exact compound and limitations kept visible. Start with the Evidence Finder, then follow the original source.

Peptide Guides

Compound identities, selected study findings and the limits of the evidence. Refreshed guides link directly to primary sources.

BPC-157
Recovery

Human BPC-157 reports exist, but the studies examined here are small and uncontrolled. They do not establish reliable clinical benefit, long-term safety or equivalence between formulations and routes.

View Guide
Semaglutide
Weight Loss

Semaglutide has randomized human evidence for weight management and, in a defined population, cardiovascular risk reduction. Route, formulation, indication and trial population remain essential to interpreting those results.

View Guide
Tirzepatide
Weight Loss

Tirzepatide is a dual GIP/GLP-1 receptor agonist with large randomized human trials. Evidence for specified prescription products should not be transferred to unverified vials or self-directed treatment schedules.

View Guide
Retatrutide
Weight Loss

Retatrutide targets GIP, GLP-1 and glucagon receptors. Randomized human studies show substantial weight reductions, but trial results do not establish the identity, safety or efficacy of online research products.

View Guide
TB-500
Recovery

TB-500 is not a sufficiently precise identity on its own. A primary analytical paper identified acetylated LKKTETQ in one product; that does not make every TB-500 product equivalent to full-length thymosin beta-4.

View Guide
CJC-1295
Performance

Human studies of long-acting CJC-1295 measured growth-hormone and IGF-I responses. They do not establish equivalent exposure for no-DAC products or demonstrate general anti-aging, muscle-building or fat-loss benefits.

View Guide
Ipamorelin
Performance

Ipamorelin can stimulate GH under studied conditions. Human pharmacology and postoperative research do not establish a general anti-aging, sleep, muscle or fat-loss treatment, and preclinical selectivity is not a human safety guarantee.

View Guide
PT-141
Performance

PT-141 is bremelanotide, a melanocortin receptor agonist. Clinical evidence and the Vyleesi approval concern a defined formulation and population—not a general sexual-performance claim or every product sold under the molecule's name.

View Guide
GHK-Cu
Anti-Aging

Foundational GHK-Cu papers include fibroblast culture and rat wound experiments. They support specific research observations, not blanket claims of human rejuvenation or systemic treatment benefit.

View Guide
Epithalon
Anti-Aging

Epithalon has laboratory telomerase findings. Human reports using Epithalamin are not automatically trials of this defined tetrapeptide, and telomere changes do not establish longer or healthier human life.

View Guide
Selank
Recovery

Selank has published human research. Small active-comparator and imaging studies need to be read on their own terms, not converted into guaranteed anxiety relief, cognitive enhancement or a personal regimen.

View Guide
DSIP
Recovery

DSIP has small human sleep experiments, not a uniformly positive clinical record. A controlled insomnia study found weak effects and no change in subjective sleep quality.

View Guide
AOD-9604
Weight Loss

AOD-9604 has animal experiments and human development history. The key distinction is that promising mouse findings did not establish clinically useful weight loss in the larger oral human trial reviewed by FDA.

View Guide
BPC-157 + TB-500 Blend
Recovery

A small uncontrolled human report included BPC-157 with thymosin beta-4, but it does not establish that an unspecified BPC/TB-500 product is effective, safe or synergistic.

View Guide
Cagrilintide
Weight Loss

Cagrilintide is a long-acting amylin analogue studied alone and with semaglutide. Human trial findings are substantial, but combination results cannot be assigned to cagrilintide alone or to an unverified blend.

View Guide
CJC-1295 + Ipamorelin Blend
Performance

Different endocrine pathways can motivate combination research, but they do not prove a CJC/ipamorelin blend is superior or safe. The first question is whether the CJC component is the albumin-binding study molecule or a separately identified no-DAC material.

View Guide
Glow Blend
Anti-Aging

GLOW is a marketed blend of GHK-Cu, BPC-157 and TB-500. Its component studies address different materials and models; they do not add up to a demonstrated clinical benefit from the finished three-component product.

View Guide
Ipamorelin + Tesamorelin Blend
Performance

A finished ipamorelin/tesamorelin blend needs its own identity, content, stability and clinical evidence. Published studies of the individual agents do not establish the mixture's efficacy, safe handling or an optimal ratio.

View Guide
Kisspeptin-10
Performance

Kisspeptin-10 can affect LH secretion under studied conditions, but responses differ by physiological context. Small hormone experiments are not proof of improved fertility, lasting testosterone benefit or a broadly safe personal regimen.

View Guide
KLOW
Research blend

KLOW is a marketed blend name, not a single peptide or a demonstrated weight-loss treatment. Start with the ingredient list and the exact molecules before drawing conclusions from research.

View Guide
L-Carnitine
Weight Loss

L-carnitine has human research and prescription uses, but neither supports treating every carnitine product as an established fat-loss intervention. The clearest reading separates the molecule, formulation, route, population and outcome.

View Guide
LIPO-C
Weight Loss

LIPO-C is a formulation name, not a single peptide. The Heritage listing describes a methionine–inositol–choline solution; biochemical roles of those ingredients do not by themselves establish a weight-loss benefit from the mixture.

View Guide
LL-37
Recovery

LL-37 has human topical wound studies, including a larger trial without significant overall healing benefit. Its normal biological role does not establish that external administration is uniformly beneficial or safe.

View Guide
MOTS-C
Performance

The selected MOTS-c papers describe cells, mouse interventions and endogenous human measurements. They do not establish the efficacy of administered native MOTS-c in people; CB4211 is a separately named investigational intervention.

View Guide
NAD+
Anti-Aging

NAD+ is a coenzyme, not a peptide. Small human infusion studies describe metabolite handling and tolerability; they do not establish general rejuvenation, disease treatment or long-term safety.

View Guide
Semax
Recovery

Semax has human and animal research, but brain imaging, rehabilitation outcomes and rodent neurotrophin measurements answer different questions. None justifies a universal cognitive-enhancement promise.

View Guide
Sermorelin
Performance

Sermorelin has a specific pediatric and diagnostic history. The selected child-growth study and FDA's Geref record do not validate general adult rejuvenation claims or make every compounded or research formulation equivalent to the historical medicine.

View Guide
SLU-PP-332
Performance

SLU-PP-332 is an experimental small molecule, not a peptide. Its published preclinical findings do not establish a human exercise replacement, weight-loss regimen or safe personal dose.

View Guide
SNAP-8
Anti-Aging

SNAP-8 is acetyl octapeptide-3. Human research includes a multi-ingredient dissolving-microneedle patch, but that is not proof of isolated SNAP-8 efficacy or systemic injection safety.

View Guide
Tesamorelin
Performance

Tesamorelin has randomized clinical evidence and a specific approved-product context for excess abdominal fat in adults with HIV-associated lipodystrophy. That is not a general weight-loss indication.

View Guide
Bacteriostatic Water
Supplies

Bacteriostatic water is a preserved diluent, not a universal peptide formulation. The exact product label, compatible material, container and intended use determine what can be concluded about a preparation.

View Guide
Acetic Acid Water
Supplies

A clear solution is not proof of a stable or injectable preparation. Acetic acid can be part of a particular laboratory formulation, but solvent choice and storage conditions must be validated for the exact material.

View Guide

Precision Matters

01

Reconstitution Is Not Optional

Lyophilized peptides require precise reconstitution with bacteriostatic water. The ratio of solvent to peptide determines your concentration — and every downstream calculation depends on getting this right.

02

Exposure Depends on the Experiment

A reported exposure belongs with its study model, route, formulation and measured endpoint. It is not a personal dosing recommendation.

03

Syringe Math Saves Vials

Understanding how concentration translates to syringe units on a 100-unit insulin syringe eliminates waste. Our calculator does this math instantly — so every vial is used efficiently.

Reconstitution Calculator

Calculate injection volumes, syringe units, and doses per vial based on your reconstitution parameters.

Parameters

Enter your reconstitution variables below.

Results

Calculated values update in real time.

Concentration per 0.1 mL --mcg
Injection Volume --mL
Syringe Units --units
Total Doses per Vial --doses
Syringe Fill (100-unit insulin syringe)
-- units

Read the study behind the claim

Mechanisms, laboratory tests and clinical outcomes answer different questions.

Read an analytical report

Separate identity, purity, content and microbiological tests without treating one result as all of them.

Interpret a clinical trial

Keep registration, recruitment, results and publication distinct. Follow the study identifier to the source.

Built on Evidence

01

Peer-Reviewed Sources

Compound guides link directly to the studies they discuss and distinguish laboratory observations, animal experiments and clinical findings.

02

Research First

Follow the original study to inspect its methods, results and limitations. Product documentation and clinical research answer different questions.

03

Continuously Updated

Follow the original paper from each guide, explore related studies in the Evidence Finder, or contact the publication with a factual correction.

About Peptide Mag

Nate Cordero, MBA

Editorial contact

Peptide Mag explains research with source links, exact compound identities and explicit evidence boundaries. New and refreshed reference pages use the organization byline Peptide Mag Editorial. The contributor and editorial-policy pages explain responsibility and review status.

nate@peptidemag.com

Peptide Mag is a publication about peptides and related research compounds. Its reference library connects accessible explanations with primary papers, trial records and analytical context.


Our goal is straightforward: provide accurate, well-sourced reference material without the noise. Just research data, clearly presented.

Medical Disclaimer

Peptide Mag explains research through compound guides, primary papers and analytical references. It does not provide personal treatment protocols.

Contact Peptide Mag